MSD Animal Health, a division of Merck, adds aquaculture outfit to its portfolio.
In a press release, pharma giant MSD Animal Health writes that it has completed of its acquisition of Vaki, an Icelandic equipment developer and manufacturer for both fish farming and river stock management.
It acquired it from the water treatment company Pentair.
“Vaki will be a leading brand under the Biomark business within MSD Animal Health, focused on a range of equipment, products and technology for fish counting and size estimation from freshwater to saltwater rearing, while collecting data and analytics for each stage of fish production,” MSD Animal Health wrote.
Biomark specialises in electronic identification technology used in fisheries, wildlife and aquaculture research, including product sales, custom manufacturing, installation and data management and analysis.
“Animal health intelligence and enhanced technology play an increasingly important role in animal health and care, providing access to real-time actionable data and insights to help, improve or enhance animal management and health outcomes,” said MSD Animal Health president Rick DeLuca.
“We continue to execute upon our strategy to expand and add breadth to our portfolio and its technology. We are at the technological forefront of shaping the future of animal health through our commitment to leveraging our scientific capabilities and expertise through comprehensive solutions to manage the health and well-being of animals. We are excited to take this step forward with Vaki, as we add leading technology and services, which extend the range of solutions in aquaculture we can provide to our customers.”
Executive vice president and Pentair CEO Karl Frykman said: “We are proud of Vaki’s transformation over the past years. Vaki has significant potential to continue to spearhead development in the aquaculture industry and we believe that MSD Animal Health is an ideal partner to support the next stage of its growth.”
